Novartis inks $1B-plus biobucks deal with Flagship's Generate
Novartis has inked a deal potentially worth more than $1 billion with Flagship-founded Generate:Biomedicines to develop protein...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
bottom of page